CITIUS PHARMACEUTICALS INC shareholders Q3 2023

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

CITIUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Key Bridge Compliance, LLC 154,130$105,4870.03%
CHELSEA COUNSEL CO 81,300$55,6420.03%
Inspire Advisors, LLC 186,410$127,5790.02%
Horst & Graben Wealth Management LLC 75,722$51,8240.01%
GSA CAPITAL PARTNERS LLP 198,492$1360.01%
Arkadios Wealth Advisors 100,000$68,4400.01%
Miller Investment Management, LP 50,000$34,2200.01%
XTX Topco Ltd 29,077$19,9000.00%
Measured Wealth Private Client Group, LLC 10,000$6,8440.00%
Pasadena Private Wealth, LLC 10,965$7,5040.00%
Csenge Advisory Group 15,000$10,2660.00%
Princeton Global Asset Management LLC 4,000$2,7380.00%
Kestra Advisory Services, LLC 91,642$62,7200.00%
OSAIC HOLDINGS, INC. 72,406$49,5540.00%
FMR LLC 2,530$1,7310.00%
FRANKLIN RESOURCES INC 14,274$9,7690.00%
AMERICAN INTERNATIONAL GROUP, INC. 61,331$41,9750.00%
BANK OF AMERICA CORP /DE/ 103,577$70,8470.00%
WELLS FARGO & COMPANY/MN 33,928$23,2210.00%
NORTHERN TRUST CORP 1,054,265$721,5390.00%
External links

This page lists CITIUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view CITIUS PHARMACEUTICALS INC's shareholder history, click here.